Marrone Bio Innov (MBII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,388 | -10,749 | -38,794 | -21,698 | -7,896 |
| Depreciation Amortization | 356 | 184 | 613 | 447 | 288 |
| Accounts receivable | -935 | -73 | -2,523 | -52 | -613 |
| Accounts payable and accrued liabilities | 2,196 | 138 | 1,174 | 1,485 | 885 |
| Other Working Capital | -3,333 | -2,389 | -2,446 | -2,145 | -1,874 |
| Other Operating Activity | -305 | 5,214 | 19,551 | 6,632 | -15 |
| Operating Cash Flow | $-14,409 | $-7,675 | $-22,425 | $-15,331 | $-9,225 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 2,000 | 2,000 | 662 |
| PPE Investments | -1,338 | -432 | -2,757 | -2,149 | -358 |
| Investing Cash Flow | $-1,338 | $-432 | $-757 | $-149 | $304 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,229 | N/A | 41,951 | 18,450 | 18,450 |
| Debt Repayment | -9,401 | -9,249 | -1,863 | -1,330 | -867 |
| Common Stock Issued | 11 | 2 | 24 | 22 | 13 |
| Other Financing Activity | 9,139 | 9,139 | -9,139 | 0 | 0 |
| Financing Cash Flow | $9,978 | $-108 | $30,973 | $17,142 | $17,596 |
| Beginning Cash Position | 10,006 | 10,006 | 2,215 | 2,215 | 2,215 |
| End Cash Position | 4,237 | 1,791 | 10,006 | 3,877 | 10,890 |
| Net Cash Flow | $-5,769 | $-8,215 | $7,791 | $1,662 | $8,675 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,409 | -7,675 | -22,425 | -15,331 | -9,225 |
| Capital Expenditure | -1,338 | -432 | -2,757 | -2,149 | -358 |
| Free Cash Flow | -15,747 | -8,107 | -25,182 | -17,480 | -9,583 |